The Revolving Door: A Visual Map of Who Goes From Regulator to Lobbyist

The revolving door is a documented, tracked, and publicly disclosed career pipeline between government regulatory agencies and the industries those agencies are supposed to regulate. It's legal. It's common. And it's one of the most effective corruption mechanisms in American public life precisely because it doesn't require anyone to break any laws.

How It Works

A regulator spends years at the FDA, SEC, FTC, EPA, or Pentagon. They develop expertise, relationships, and, critically, an understanding of exactly how the regulatory system works, where its gaps are, and which arguments are most effective at influencing agency decisions.

Then they leave. They join the industry they regulated, typically at a salary 5-10x what they earned in government. Their value isn't generic business skills. It's their specific knowledge of how to navigate the agency they just left.

Finance: The SEC to Wall Street Pipeline

The Securities and Exchange Commission is the most well-documented revolving door in American finance. ProPublica and OpenSecrets have tracked thousands of former SEC employees moving to financial firms, law firms, and lobbying operations. Former SEC enforcement attorneys who spent years building cases against financial fraud now work at law firms defending financial firms from SEC enforcement cases.

The institutional knowledge flows out. The enforcement capacity depletes. The cycle continues.

Defense: The Pentagon to Contractor Superhighway

Senior Pentagon procurement officials who made acquisition decisions worth billions routinely leave government service for board seats at the exact contractors they oversaw. There is a mandatory cooling-off period of one to two years — during which many simply consult rather than lobby formally.

The Project On Government Oversight found that from 2008 to 2018, the top 20 defense contractors employed over 600 former senior government officials.

Pharma and the FDA

FDA officials who oversee drug approvals move to pharmaceutical companies with striking regularity. Former FDA commissioners have become pharma board members. Former division directors who oversaw approval decisions join the companies whose drugs they evaluated.

The effect is structurally obvious: when regulators know their future employers are watching, the incentives for aggressive enforcement shift.

Why Cooling-Off Periods Don't Work

The standard reform proposal is longer cooling-off periods. The problem is that most of the value isn't in direct lobbying. It's in strategy sessions at law firms and consulting companies. It's in knowing which career staffers to call. You can ban a former regulator from walking into the building.

You can't ban them from sharing everything they know over lunch. Until there's political will to impose genuine lifetime bans on lobbying former agencies the revolving door will keep spinning.

Stay Frustrated